Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2010

Total Assets: $16.2M

Liabilities Breakdown FY2010

Total Liabilities: $5.8M